Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Identification of ERF-1 as a member of the AP2 transcription factor family.

McPherson LA, Baichwal VR, Weigel RJ.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4342-7.

2.

Activate NF-kappa B or die?

Baichwal VR, Baeuerle PA.

Curr Biol. 1997 Feb 1;7(2):R94-6. Review.

3.

NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

Baeuerle PA, Baichwal VR.

Adv Immunol. 1997;65:111-37. Review. No abstract available.

PMID:
9238509
4.
5.

Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1.

Neish AS, Khachigian LM, Park A, Baichwal VR, Collins T.

J Biol Chem. 1995 Dec 1;270(48):28903-9.

8.

Transcription factor based therapeutics: drugs of the future?

Peterson MG, Baichwal VR.

Trends Biotechnol. 1993 Jan;11(1):11-8. Review.

PMID:
7763378
9.
10.

v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor.

Baichwal VR, Park A, Tjian R.

Nature. 1991 Jul 11;352(6331):165-8.

PMID:
1906140
13.

Characterization of the BNLF-1 oncogene of Epstein-Barr virus.

Baichwal VR, Hammerschmidt W, Sugden B.

Curr Top Microbiol Immunol. 1989;144:233-9. No abstract available.

PMID:
2551585
15.

Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.

Baichwal VR, Sugden B.

Oncogene. 1988 May;2(5):461-7.

PMID:
2836780
16.

Latency comes of age for herpesviruses.

Baichwal VR, Sugden B.

Cell. 1988 Mar 25;52(6):787-9. Review. No abstract available.

PMID:
2832064

Supplemental Content

Loading ...
Support Center